Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advancements in the Field of Personalized Medicine
4.2.2 Rising Burden of Cancer
4.2.3 Decrease in Costs for Genetic Sequencing
4.3 Market Restraints
4.3.1 Lack of computational efficiency for data management
4.3.2 Inadequate Reimbursement Policy
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 Technology
5.1.1 Whole Genome Sequencing
5.1.2 Whole Exome Sequencing
5.1.3 Targeted Sequencing & Resequencing Centrifuges
5.2 Workflow
5.2.1 Pre-Sequencing
5.2.2 Sequencing
5.2.3 Data Analysis
5.3 Application
5.3.1 Screening
5.3.1.1 Sporadic Cancer
5.3.1.2 Inherited Cancer
5.3.2 Companion Diagnostics
5.3.3 Other Diagnostics
5.4 End-use
5.4.1 Hospitals
5.4.2 Clinics
5.4.3 Laboratories
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Illumina, Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 F. Hoffmann-La Roche Ltd.
6.1.4 Agilent Technologies
6.1.5 Myriad Genetics
6.1.6 Beijing Genomics Institute (BGI)
6.1.7 Perkin Elmer
6.1.8 Foundation Medicine
6.1.9 Pacific Bioscience
6.1.10 Oxford Nanopore Technologies Ltd.
6.1.11 Exact Science
6.1.12 Caris Life Sciences
6.1.13 Partek, Inc.
6.1.14 Eurofins Scientific S.E.
6.1.15 Qiagen N.V.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS